LXRX vs MLM · rev $21.8M vs P/E 36, rev $1.95B
Lexicon Pharmaceuticals Inc (LXRX) versus Martin Marietta Materials Inc (MLM) — a side-by-side from cached financials, not a winner call.
Lexicon Pharmaceuticals Inc (LXRX) is a biotechnology company listed on US.
Martin Marietta Materials Inc (MLM) is a building materials company listed on US.
Latest reported LXRX revenue for 2026-06-30 was $21.8M. Net income was -$32.8M. Revenue was up 3.3% from 2026-03-31 to 2026-06-30. LXRX currently screens at market cap $327.2M.
Latest reported MLM revenue for 2026-06-30 was $1.95B. Net income was $251.0M. Revenue was up 43.0% from 2026-03-31 to 2026-06-30. MLM currently screens at market cap $34.63B and trailing P/E 36.2.
LXRX currently screens at market cap $327.2M. MLM currently screens at market cap $34.63B and trailing P/E 36.2.
Not investment advice. Open the LXRX and MLM stock pages for the full models.
Not investment advice.